We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.Who We Are
Ken Peartree is an Operations and product development executive with a 25-year track record of bringing new medical technologies to market. He has commercialized products in a range of surgical specialties including general surgery, vascular surgery, urology, and ophthalmology. In 2011 Ken founded Ocunetics, Inc. and sold its technology to Iridex Corp where he remained as VP of R&D until 2015. Ken’s previous experience includes Axiom Technology Partners, acquired by Teleflex in 2012, as well as General Surgical Innovations, Inc., acquired by Tyco Healthcare. Ken graduated from UC Berkeley’s College of Engineering and holds an MBA from the Columbia Business School in New York.
“At our core, Q’Apel is about people. Our dedicated team is singularly focused on providing the best performing and highest quality neurovascular devices to the physicians and patients we serve.”
By working side by side with neurological specialists and caregivers, we craft solutions that get straight to the heart of what’s needed. Reach out to learn more.